inSoma Bio
PrivateLast Round
Accelerator
Jun 5, 2025
Est. Valuation
$1.79M
Total Funding Raised
$10.54M
Company Overview
inSoma Bio is a biotechnology company that develops bioengineered reconstructive biomaterials for plastic and reconstructive surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inSoma Bio Comparables
Compare inSoma Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeSprout | 83% | |
| Healshape | 79% | |
| BellaSeno | 79% |
inSoma Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 5, 2025 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Mar 31, 2023 | ||||
| Grant | Dec 15, 2022 | ||||
Debt | Dec 15, 2022 |
inSoma Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Makai VC | Seed |
| MedBlue Incubator | Seed |
| Y Combinator | Pre Seed, Accelerator |
| North Carolina Biotechnology Center | Debt, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors increased 433% MoM.
- Jun 5, 2025
Received funding from MedTech Innovator.
inSoma Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about inSoma Bio's valuation, stock price, and market status.
Is inSoma Bio a public or private company?
inSoma Bio is a private company.
What is the current stock price of inSoma Bio?
inSoma Bio is a private company with no public stock price. No recent secondary market data is available.
How much is inSoma Bio worth (valuation)?
Valuation information for inSoma Bio is not publicly available.
Can I buy inSoma Bio stock?
inSoma Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was inSoma Bio's last funding round?
inSoma Bio's most recent funding round was Accelerator on June 5, 2025.
Who are the main investors in inSoma Bio?
Key investors in inSoma Bio include National Cancer Institute, MedTech Innovator, NIH RADx, Y Combinator, North Carolina Biotechnology Center.
Will inSoma Bio IPO soon?
No public IPO plans have been announced for inSoma Bio.
How can I track inSoma Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor inSoma Bio's secondary market activity and sign up for updates.